Cedara has received FDA clearance for its I-ReadMammo breast imaging workstation. The new product, which supports images from multiple modalities and various mammography vendors (SCAN 5/5/04), will begin shipping this summer. It will be marketed directly
Cedara has received FDA clearance for its I-ReadMammo breast imaging workstation. The new product, which supports images from multiple modalities and various mammography vendors (SCAN 5/5/04), will begin shipping this summer. It will be marketed directly by Cedara, as well as through OEMs and distributors.
Can a Deep Learning Algorithm Enhance Detection of Prostate Cancer Recurrence with Biparametric MRI?
September 26th 2023For patients who had previous radiotherapy for prostate cancer (PCa), researchers found that a biparametric MRI-based deep learning model demonstrated an 81.5 percent sensitivity rate for PCa recurrence in patients previously treated with external beam radiation treatment (EBRT) and 100 percent sensitivity in patients with greater than 34 ml in gland volumes.
2 Clarke Drive
Cranbury, NJ 08512